Altimmune to report fourth quarter and full year 2023 financial results and provide business update on march 27, 2024

Gaithersburg, md., march 20, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that it will report its fourth quarter and full year 2023 financial results on wednesday, march 27, 2024 and will provide a business update.
ALT Ratings Summary
ALT Quant Ranking